Details About Generic Salt ::  Tiludron

Main Medicine Class:: Hormone,biphosphonates   

(tie-LOO-droe-nate)

Skelid

Class: Hormone/biphosphonates

 

Drugs Class ::

 Action Inhibits normal and abnormal bone resorption.

Indications for Drugs ::

 Indications Treatment of Paget’s disease of bone.

Drug Dose ::

 Route/Dosage

ADULTS: PO 400 mg qd for 3 months.

Contraindication ::

 Contraindications Standard considerations.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Renal function impairment: Not recommended in patients with CrCl < 30 ml/min.

PATIENT CARE CONSIDERATIONS

Drug Side Effects ::

 Adverse Reactions

CV: Hypertension; syncope. CNS: Paresthesia; vertigo; somnolence; anxiety; nervousness; insomnia; involuntary muscle contractions. DERM: Rash; pruritis; sweating. GI: Diarrhea; nausea; constipation; vomiting; flatulence; abdominal pain; norexia; dry mouth; gastritis. META: Hyperparathyroidism. EENT: Cataract; conjunctivitis; glaucoma; rhinitis; sinusitis; pharyngitis. OTHER: Fatigue; asthenia; chest pain; edema; arthrosis; flushing.

Drug Mode of Action ::  

 Action Inhibits normal and abnormal bone resorption.

Drug Interactions ::

 Interactions

Aspirin, calcium, aluminum- or magnesium-containing antacids: Decrease tiludronate bioavailability. Indomethacin: Increases tiludronate bioavailability.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies. Note any hypersensitivity to biphosphonates and evidence of renal function impairment.
• Record dates of any previous treatment with tiludronate.
• Monitor patient for side effects.

OVERDOSAGE: SIGNS & SYMPTOMS   Hypocalcemia

Drug Storage/Management ::

 Administration/Storage

• Have patient take drug on empty stomach 2 hr before or after meals.
• Swallow tablet with 6–8 oz of plain water. Do not use beverages other than plain water (eg, mineral water).
• Calcium or mineral supplements should be taken at least 2 hours before or after tiludronate.
• Aluminum or magnesium-containing antacids, if needed, should be taken at least 2 hr after taking tiludronate.
• Administer aspirin or indomethacin, if ordered, either 2 hr before or after tiludronate.
• The 3 month course of treatment may be repeated in some patients following a 3 month tiludronate-free interval.
• Store at controlled room temperature. Do not remove from foil strip until ready for administration.

Drug Notes ::

 Patient/Family Education

• Instruct patient to take drug with 6–8 oz of plain water. Advise patient to not use any other beverage (eg, mineral water).
• Instruct patient to avoid eating 2 hr before and 2 hr after taking medication since absorption of drug is reduced by food.
• Instruct patient to maintain adequate intake of vitamin D and calcium.
• Advise patient to take calcium or mineral supplements 2 hr before or 2 hr after tiludronate.
• Advise patient to take aluminum- or magnesium-containing antacids at least 2 hr after tiludronate.
• Advise patients taking aspirin or indomethacin to take these 2 hr before or after tiludronate.
• Advise patient to not remove medication from foil strip until just before administration.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.